Public Calendar: February 8 -14, 2026
This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.
Official Name: Martin A. Makary, M.D., M.P.H., Commissioner for Food and Drugs
Event Date: 02/10/2026
Location: Washington, DC
Subject: Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Senator Jon Husted (R-OH)
Event Date: 02/10/2026
Location: Washington, DC
Subject: Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Representative Diana Harshbarger (R-TN)
Event Date: 02/10/2026
Location: Washington, DC
Subject: Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Drew Keyes, Eric Schmitz (House Speaker (Republican) Office);
Event Date: 02/10/2026
Location: Washington, DC
Subject: Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Representative August Pfluger (R-TX)
Event Date: 02/11/2026
Location: Silver Spring, MD
Subject: Expanded FDA Initiative on Smoke-Free Products Across the Wider HHS Organization
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Philip Morris International (PMI) representatives
Official Name: Sara Brenner, M.D., M.P.H., Principal Deputy Commissioner for Food and Drugs
No Significant Event
Official Name: Sean R. Keveney, Chief Counsel
No Significant Event
Official Name: Grace Graham, Deputy Commissioner for Policy, Legislation, and International Affairs
No Significant Event
Official Name: Kyle Diamantas, J.D., Deputy Commissioner for Human Foods
Event Date: 02/11/2026
Location: Yuma, AZ
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Arizona Department of Agriculture officials, National Association of State Departments of Agriculture officials, produce industry, academia, and trade associations
Official Name: Barclay Butler, Ph.D., Deputy Commissioner for Operations
No Significant Event
Official Name: Lowell Zeta, J.D., Deputy Commissioner for Strategic Initiatives
Event Date: 02/10/2026
Location: Virtual
Subject: Issues of Mutual Interest
FDA Participant/Group: LUKE HALL; BRIAN FAHEY;
Non FDA Participant/Group: American Society of Gene and Cell Therapy (ASGCT) representatives
Event Date: 02/12/2026
Location: Virtual
Subject: Clarifying Processes to Maintain Alignment on Clinical Study Design
FDA Participant/Group: LUKE HALL; KARIM MIKHAIL; BRIAN FAHEY;
Non FDA Participant/Group: John Stone (BGR Government Affairs, LLC); Tim Hunt (Alliance for Regenerative Medicine);
Official Name: Elizabeth Miller, Pharm.D., Associate Commissioner for Inspections and Investigations
No Significant Event
Official Name: Vinayak Prasad, M.D., M.P.H., Director, Center for Biologics and Research
No Significant Event
Official Name: Michelle Tarver, M.D., Ph.D., Director, Center for Devices and Radiological Health
Event Date: 02/12/2026
Location: Washington, DC
Subject: Assistant Secretary for Technology Policy (ASTP) Annual Meeting; Panelist: Accelerating Artificial Intelligence Adoption as Part of Clinical Care
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, government, media, and other registered attendees
Event Date: 02/13/2026
Location: Silver Spring, MD
Subject: General Medical Device Updates on Wearable Technology and Artificial Intelligence
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Consumer Technology Association representatives
Official Name: Tracy Beth Høeg M.D., Ph.D., Acting Director, Center for Drug Evaluation and Research
No Significant Event
Official Name: Bret Koplow, Ph.D., J.D., Acting Director, Center for Tobacco Products
No Significant Event
Official Name: Timothy Schell, Ph.D., Director, Center for Veterinary Medicine
No Significant Event